According to the website of European political weekly, with the increase of monkeypox cases in European countries, some countries began to rush to buy monkeypox vaccine. Although the who has warned that the global supply of monkeypox vaccine is limited, there is no need to stockpile vaccines when there are still relatively few cases in Europe, but only need to strengthen the detection, tracking and management of cases**
According to the report, only the monkeypox vaccine developed by Denmark is available in Europe. The vaccine investor said that many countries and institutions are negotiating the purchase with the manufacturers of imvanex vaccine, including the health emergency department of the European Commission and the WHO.
It is reported that so far, the UK has vaccinated 1000 doses of vaccine for close contacts and medical workers of monkeypox patients and stockpiled 3500 doses. France announced on the 24th that it has begun vaccinating high-risk groups to prevent the spread of the epidemic.
The good news about the monkeypox epidemic is that a variety of vaccines and treatments have been approved. The bad news is that "the number of vaccines is extremely limited, and several of them have not been fully licensed," Sylvie briander, who director of global infectious disease risk prevention, said at the World Health Assembly on the 24th. She urged countries to work together to ensure equitable distribution of vaccines and diagnostic methods.
According to the report, some global epidemic researchers also believe that there is no need for mass vaccination of monkeypox vaccine at present, because the virus is completely different from novel coronavirus, and the mode of transmission is also different. (compiled by / Yang Wenjing)